Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a large decrease in short interest in September. As of September 15th, there was short interest totalling 1,900 shares, a decrease of 50.0% from the August 31st total of 3,800 shares. Based on an average daily trading volume, of 11,600 shares, the days-to-cover ratio is currently 0.2 days.

Alpha Tau Medical Price Performance

Shares of Alpha Tau Medical stock remained flat at $0.19 during mid-day trading on Thursday. 10,882 shares of the stock traded hands, compared to its average volume of 11,203. The firm’s 50-day simple moving average is $0.20 and its 200-day simple moving average is $0.23. Alpha Tau Medical has a twelve month low of $0.09 and a twelve month high of $0.32.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.